Related Experiment Video
Updated: Oct 3, 2025

07:22
Minimally Invasive Murine Laryngoscopy for Close-Up Imaging of Laryngeal Motion During Breathing and Swallowing
Published on: December 1, 2023
692
Pharyngeal electrical stimulation in amyotrophic lateral sclerosis: a pilot study
Christine Herrmann1, Falk Schradt1, Beate Lindner-Pfleghar1
1Department of Neurology, University of Ulm, Ulm, Germany.
Therapeutic Advances in Neurological Disorders
|February 14, 2022
Summary
Pharyngeal electrical stimulation (PES) did not significantly improve swallowing in ALS patients compared to standard therapy alone. Standard logopaedic therapy (SLT) alone showed short-term benefits for swallowing function and quality of life in ALS patients.
Area of Science:
- Neurology
- Gastroenterology
- Rehabilitation
Background:
- Amyotrophic lateral sclerosis (ALS) frequently causes dysphagia, increasing risks of aspiration, pneumonia, and weight loss.
- Pharyngeal electrical stimulation (PES) is a technique aimed at improving swallowing by leveraging cortical plasticity.
- Prior research indicates PES benefits patients with various neurological conditions.
Purpose of the Study:
- To evaluate the efficacy of PES in enhancing swallowing function among ALS patients with severe dysphagia.
- To compare the effects of PES combined with Standard Logopaedic Therapy (SLT) versus SLT alone.
Main Methods:
- Twenty ALS patients with severe dysphagia (Penetration Aspiration Scale [PAS] ≥ 4) were randomized into two groups: PES + SLT or SLT alone.
- Swallowing function was assessed using Fiberoptic Endoscopic Evaluation of Swallowing (FEES) at multiple time points.
- Primary endpoint was PAS score; secondary endpoints included quality of life, dysphagia severity, and functional status.
Main Results:
- A significant short-term improvement in median Total-PAS was observed across both groups combined post-treatment.
- No significant difference in swallowing function was found between the PES and control groups one day after intervention.
- While PAS scores increased after the initial improvement, they remained below baseline levels throughout the study.
Conclusions:
- PES does not appear to offer additional benefits for swallowing function in ALS patients beyond standard therapy.
- Standard Logopaedic Therapy (SLT) alone demonstrates potential for short-term improvements in swallowing function and quality of life for ALS patients.
- Further research may be needed to explore optimal therapeutic strategies for dysphagia in ALS.

